Morning Research: Johnson & Johnson, Mylan, Array BioPharma, and Brookdale Senior Living

  Morning Research: Johnson & Johnson, Mylan, Array BioPharma, and Brookdale
                                Senior Living

PR Newswire

LONDON, July 24, 2013

LONDON, July 24, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Tuesday, July 23, 2013, shares in healthcare companies ended on a mixed
note, tracking the broader market. The major movers in the sector included
Johnson & Johnson (NYSE: JNJ), Mylan Inc. (NASDAQ: MYL), Array Biopharma Inc.
(NASDAQ: ARRY), and Brookdale Senior Living Inc. (NYSE: BKD).
AAAResearchReports.com has released full comprehensive research on JNJ, MYL,
ARRY, and BKD. These free technical analyses can be downloaded by signing up
at:

http://www.aaaresearchreports.com/register/ 

Shares in Johnson & Johnson edged higher on Tuesday, extending their gains
from previous trading sessions. The company's shares hit a 52-week high of
$92.86 before finishing the day 0.15% higher at $92.42. A total of 8.47
million shares were traded which is below the daily average volume of 10.01
million. Johnson & Johnson's shares gained 2.50% in the last three trading
sessions and 11.08% in the last one month as compared to a gain of 0.18% and
6.28% in the S&P 500 during the respective periods. Download free report on
JNJ upon registration at:

http://www.AAAResearchReports.com/JNJ072413.pdf

Mylan Inc.'s stock slipped on Tuesday, reversing most of its recent gains. The
company's shares oscillated between $32.15 and $32.75 before closing the day
1.01% lower at $32.32. A total of 3.82 million shares were traded which is
slightly above the daily average volume of 3.81 million. The company's stock
has gained 0.06% in the last three trading sessions, and it is currently
trading near its 52-week high of $33.07. MYL technical report can be accessed
for free by signing up at:

http://www.AAAResearchReports.com/MYL072413.pdf

Shares in Array Biopharma Inc. surged on Tuesday, hitting a 52-week high of
$6.64. The company's shares ended the session 10.43% higher at $6.14. A total
of 11.36 million shares were traded which is above the daily average volume of
1.42 million. The stock has gained 13.08% in the last three trading and 22.68%
in the last one month, thus outperforming the S&P 500 during the respective
periods. The free report on ARRY can be downloaded by signing up now at:

http://www.AAAResearchReports.com/ARRY072413.pdf

Brookdale Senior Living Inc.'s stock fell sharply on Tuesday, finishing at
$28.93, down 2.13% from its previous closing price. The company's shares
oscillated between $28.83 and $29.62. A total of 1.02 million shares were
traded which is below the daily average volume of 1.10 million. Despite
Tuesday's pullback, Brookdale Senior Living's shares are trading near their
52-week high of $30.34, and also above their 50-day and 200-day moving
averages. A free report on BKD can be accessed by registering at:

http://www.AAAResearchReports.com/BKD072413.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE AAA Research Reports

Contact: AAAresearchreports.com Phone #: + 1 (646) 396-9126
 
Press spacebar to pause and continue. Press esc to stop.